Trends in Medicare spending on topical immunomodulators and chemotherapies

J Am Acad Dermatol. 2018 Jan;78(1):173-175. doi: 10.1016/j.jaad.2017.07.056.

Authors

Hannah Song¹, Adewole S Adamson², Arash Mostaghimi³

Affiliations

¹ Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts.
² Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
³ Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: [email protected].

PMID: 29241774
DOI: 10.1016/j.jaad.2017.07.056

No abstract available

Publication types

Letter

MeSH terms

Administration, Topical
Dermatologic Agents / economics*
Dermatologic Agents / therapeutic use*
Health Expenditures
Humans
Immunologic Factors / economics*
Immunologic Factors / therapeutic use*
Medicare / economics*
Medicare / trends*
United States

Substances

Dermatologic Agents
Immunologic Factors